Kiora Price to Earnings Ratio vs Free Cash Flow Analysis

KPRX Stock  USD 0.69  0.07  10.61%   
Trend analysis of Kiora Pharmaceuticals balance sheet accounts such as Total Current Liabilities of 3.2 M provides information on Kiora Pharmaceuticals' total assets, liabilities, and equity, which is the actual value of Kiora Pharmaceuticals to its prevalent stockholders. By breaking down trends over time using Kiora Pharmaceuticals balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
  
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Kiora Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.
For more information on how to buy Kiora Stock please use our How to Invest in Kiora Pharmaceuticals guide.

About Kiora Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Kiora Pharmaceuticals at a specified time, usually calculated after every quarter, six months, or one year. Kiora Pharmaceuticals Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Kiora Pharmaceuticals and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Kiora currently owns. An asset can also be divided into two categories, current and non-current.

Kiora Pharmaceuticals Balance Sheet Chart

Kiora Pharmaceuticals Balance Sheet is one of the main financial statements that report all assets, liabilities, and shareholders' equity for the current year. It provides a basis for different types of computing rates of return, such as return on equity (ROE) or return on asset (ROA), as well as shows how Kiora Pharmaceuticals uses and utilizes its capital. It also shows what exactly a company owns and owes.
At this time, Kiora Pharmaceuticals' Common Stock is fairly stable compared to the past year. Current Deferred Revenue is likely to rise to about 4.9 M in 2024, whereas Total Assets are likely to drop slightly above 11.7 M in 2024.

Total Assets

Total assets refers to the total amount of Kiora Pharmaceuticals assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Kiora Pharmaceuticals books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Kiora Pharmaceuticals balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Kiora Pharmaceuticals are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.
Most indicators from Kiora Pharmaceuticals' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Kiora Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Kiora Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.
For more information on how to buy Kiora Stock please use our How to Invest in Kiora Pharmaceuticals guide.At this time, Kiora Pharmaceuticals' Selling General Administrative is fairly stable compared to the past year. Issuance Of Capital Stock is likely to rise to about 8.7 M in 2024, whereas Tax Provision is likely to drop (136.5 K) in 2024.

Kiora Pharmaceuticals fundamental ratios Correlations

-0.490.870.230.930.73-0.68-0.820.310.670.88-0.50.670.430.26-0.880.820.95-0.870.76-0.520.490.47-0.730.610.65
-0.49-0.540.04-0.55-0.260.690.33-0.03-0.52-0.30.76-0.52-0.23-0.160.51-0.42-0.440.55-0.541.0-0.3-0.290.3-0.13-0.21
0.87-0.540.450.820.57-0.62-0.70.620.60.75-0.510.60.420.24-0.840.730.82-0.770.68-0.550.30.62-0.510.540.5
0.230.040.450.18-0.04-0.32-0.010.560.390.080.220.39-0.15-0.13-0.360.420.1-0.140.350.050.340.880.26-0.18-0.24
0.93-0.550.820.180.56-0.69-0.790.30.690.77-0.60.690.470.33-0.970.80.92-0.990.76-0.570.510.42-0.690.430.56
0.73-0.260.57-0.040.56-0.5-0.670.110.530.6-0.330.530.460.25-0.450.480.7-0.480.61-0.270.170.15-0.710.660.7
-0.680.69-0.62-0.32-0.69-0.50.31-0.15-0.96-0.270.51-0.96-0.140.090.71-0.57-0.530.69-0.950.67-0.61-0.450.31-0.03-0.08
-0.820.33-0.7-0.01-0.79-0.670.31-0.11-0.35-0.820.45-0.35-0.77-0.720.68-0.61-0.890.7-0.480.36-0.26-0.340.91-0.7-0.91
0.31-0.030.620.560.30.11-0.15-0.110.150.310.090.150.01-0.15-0.410.320.25-0.290.18-0.03-0.050.370.110.21-0.01
0.67-0.520.60.390.690.53-0.96-0.350.150.24-0.411.00.21-0.02-0.710.560.51-0.670.98-0.50.650.49-0.350.030.12
0.88-0.30.750.080.770.6-0.27-0.820.310.24-0.380.240.360.3-0.70.760.9-0.70.35-0.350.260.32-0.70.750.74
-0.50.76-0.510.22-0.6-0.330.510.450.09-0.41-0.38-0.41-0.36-0.270.53-0.38-0.520.62-0.460.77-0.26-0.090.45-0.27-0.38
0.67-0.520.60.390.690.53-0.96-0.350.151.00.24-0.410.21-0.02-0.710.560.51-0.670.98-0.50.650.49-0.350.030.12
0.43-0.230.42-0.150.470.46-0.14-0.770.010.210.36-0.360.210.89-0.340.030.54-0.410.35-0.23-0.030.09-0.670.610.8
0.26-0.160.24-0.130.330.250.09-0.72-0.15-0.020.3-0.27-0.020.89-0.210.040.42-0.260.1-0.170.020.14-0.610.430.74
-0.880.51-0.84-0.36-0.97-0.450.710.68-0.41-0.71-0.70.53-0.71-0.34-0.21-0.83-0.860.97-0.770.53-0.55-0.540.55-0.28-0.39
0.82-0.420.730.420.80.48-0.57-0.610.320.560.76-0.380.560.030.04-0.830.76-0.760.57-0.450.520.64-0.490.250.35
0.95-0.440.820.10.920.7-0.53-0.890.250.510.9-0.520.510.540.42-0.860.76-0.880.63-0.470.390.37-0.820.620.73
-0.870.55-0.77-0.14-0.99-0.480.690.7-0.29-0.67-0.70.62-0.67-0.41-0.260.97-0.76-0.88-0.740.57-0.5-0.350.63-0.34-0.47
0.76-0.540.680.350.760.61-0.95-0.480.180.980.35-0.460.980.350.1-0.770.570.63-0.74-0.530.610.48-0.460.160.26
-0.521.0-0.550.05-0.57-0.270.670.36-0.03-0.5-0.350.77-0.5-0.23-0.170.53-0.45-0.470.57-0.53-0.29-0.290.31-0.18-0.25
0.49-0.30.30.340.510.17-0.61-0.26-0.050.650.26-0.260.65-0.030.02-0.550.520.39-0.50.61-0.290.37-0.3-0.2-0.02
0.47-0.290.620.880.420.15-0.45-0.340.370.490.32-0.090.490.090.14-0.540.640.37-0.350.48-0.290.37-0.050.020.08
-0.730.3-0.510.26-0.69-0.710.310.910.11-0.35-0.70.45-0.35-0.67-0.610.55-0.49-0.820.63-0.460.31-0.3-0.05-0.59-0.83
0.61-0.130.54-0.180.430.66-0.03-0.70.210.030.75-0.270.030.610.43-0.280.250.62-0.340.16-0.18-0.20.02-0.590.88
0.65-0.210.5-0.240.560.7-0.08-0.91-0.010.120.74-0.380.120.80.74-0.390.350.73-0.470.26-0.25-0.020.08-0.830.88
Click cells to compare fundamentals

Kiora Pharmaceuticals Account Relationship Matchups

Kiora Pharmaceuticals fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets10.1M15.2M18.1M18.7M13.7M11.7M
Short Long Term Debt Total83.9K362.1K209.4K105.8K106.9K101.5K
Other Current Liab1.1M1.3M1.3M2.2M1.4M1.3M
Total Current Liabilities1.4M1.8M1.6M3.3M1.6M3.2M
Total Stockholder Equity6.6M7.0M9.2M11.4M6.1M6.4M
Property Plant And Equipment Net16.8K30.6K283.4K172.2K115.0K76.8K
Net Debt(3.7M)(823.6K)(7.6M)(5.9M)(2.3M)(2.5M)
Retained Earnings(100.2M)(108.3M)(124.7M)(134.5M)(147.0M)(154.3M)
Accounts Payable210.3K434.8K160.6K1.0M206.3K195.9K
Cash3.8M1.2M7.9M6.0M2.5M4.7M
Non Current Assets Total5.8M13.3M9.1M11.0M9.0M6.1M
Non Currrent Assets Other114.4K102.1K88.0K82.3K40.8K38.7K
Cash And Short Term Investments3.8M1.2M7.9M6.0M2.5M4.7M
Net Receivables4.9K91.0K529.6K1.4M2.0M2.2M
Common Stock Shares Outstanding79.5K114.8K241.1K732.3K4.8M5.1M
Liabilities And Stockholders Equity10.1M15.2M18.1M18.7M13.7M11.7M
Non Current Liabilities Total2.1M6.4M7.2M4.0M6.0M10.2M
Other Current Assets542.7K533.5K606.5K343.1K233.4K368.7K
Other Stockholder Equity106.7M115.3M133.9M146.0M153.2M93.1M
Total Liab3.5M8.2M8.8M7.3M7.6M12.5M
Total Current Assets4.3M1.8M9.0M7.7M4.7M5.6M
Accumulated Other Comprehensive Income139.5K(802.0)(86.4K)(182.7K)(182.8K)(173.7K)
Short Term Debt83.9K48.3K118.8K105.8K47.1K44.7K
Common Stock40.8K55.6K126.6K18.0K77.1K101.9K
Intangible Assets4.1M9.7M8.7M10.7M8.8M7.9M
Other Liab1.5M2.1M6.1M7.1M8.2M8.6M
Net Tangible Assets7.2M4.9M3.3M9.1M10.4M10.9M
Capital Lease Obligations83.9K83.9K209.4K105.8K121.6K92.4K
Net Invested Capital6.6M7.3M9.2M11.4M13.1M7.6M
Non Current Liabilities Other1.7M5.3M6.5M3.3M3.8M3.5M
Net Working Capital2.9M37.8K7.4M4.4M5.1M5.3M
Property Plant Equipment43.5K16.8K30.6K283.4K325.9K342.2K
Capital Stock40.8K55.6K126.6K18.0K16.2K15.4K

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Kiora Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Kiora Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Kiora Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Kiora Pharmaceuticals Stock:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Kiora Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.
For more information on how to buy Kiora Stock please use our How to Invest in Kiora Pharmaceuticals guide.
You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.

Complementary Tools for Kiora Stock analysis

When running Kiora Pharmaceuticals' price analysis, check to measure Kiora Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kiora Pharmaceuticals is operating at the current time. Most of Kiora Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Kiora Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kiora Pharmaceuticals' price. Additionally, you may evaluate how the addition of Kiora Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Commodity Directory
Find actively traded commodities issued by global exchanges
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Is Kiora Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Kiora Pharmaceuticals. If investors know Kiora will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Kiora Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
0.78
Revenue Per Share
0.002
Return On Assets
(0.38)
Return On Equity
(1.37)
The market value of Kiora Pharmaceuticals is measured differently than its book value, which is the value of Kiora that is recorded on the company's balance sheet. Investors also form their own opinion of Kiora Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Kiora Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Kiora Pharmaceuticals' market value can be influenced by many factors that don't directly affect Kiora Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Kiora Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Kiora Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Kiora Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.